Irina Kovaleva

Mrs. Irina Kovaleva

Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2020 in Cells
Verified
Journal Article
Open access
PDF file
LSLuidmila Spirina
Luidmila Spirina
ZYZahar A. Yurmazov
Zahar A. Yurmazov
AGAlexey K. Gorbunov
Alexey K. Gorbunov
EUEvgeny A. Usynin
Evgeny A. Usynin
NLNadejda Lushnikova
Nadejda Lushnikova
IKIrina Kovaleva
Irina Kovaleva
Metastasis involves the spread of cancer cells from the primary tumor to surrounding tissues and distant organs and is the primary cause of cancer morbidity and mortality. The aim of the study was the determination of change in molecular factors expression in primary kidney cancers (ccRCC) and metastatic sites. In total, 62 patients with RCC were enrolled in the study. The mRNA levels of molecular markers were studied by real-time PCR, and the content of the studied parameters was determined by Western blotting and ELISA. The features in the intracellular signal metabolites in the series of normal renal parenchyma, tumor tissue of localized, disseminated kidney cancer and metastatic tissue were studied. A decrease in some indicators in the tissue of the metastatic lesion was noted. Protein products of transcription factors HIF-1, CAIX, PTEN and activated AKT kinase, as well as expression of the VEGFR2 receptor and m-TOR protein kinase were revealed to be reduced in the metastatic sites. In addition, some indicators increased in metastasis: the protein levels of NF-κB p 50, NF-κB p 65, HIF-2, VEGF, VEGFR2, m-TOR and mRNA of HIF-1, CAIX, PTEN and PDK. There were indicators with multidirectional changes. HIF-1, CAIX, PTEN, VEGFR2 and m-TOR mRNA: VEGFR2, m-TOR, HIF-1, CAIX, PTEN and PDK had an opposite change in protein content and mRNA level. PTEN loss resulted in the downstream activation of AKT/mTOR signaling in secondary cancer lesions and determined the overall ccRCC patient’s survival. The AKT/mTOR signaling cascade activation was found in the primary kidney tumors. The PTEN content and mRNA level were correlated with total AKT, GSK-3β, the 70S 6 kinases and AKT expression.

Verified
Journal Article
Open access
PDF file
LSLuidmila Spirina
Luidmila Spirina
AAAlexandra V. Avgustinovich
Alexandra V. Avgustinovich
OBOlga Vladimirovna Bakina
Olga Vladimirovna Bakina
SASergey G. Afanasyev
Sergey G. Afanasyev
MVMaxim Yu. Volkov
Maxim Yu. Volkov
IMIgor O. Munkuev
Igor O. Munkuev
Heterogeneity of gastric cancer (GC) is the main trigger of the disease’s relapse. The aim of this study was to investigate the connections between targeted genes, cancer clinical features, and the effectiveness of FLOT chemotherapy. Twenty-one patients with gastric cancers (GCs) were included in this study. Tumor-targeted sequencing was conducted, and real-time PCR was used to assess the expression of molecular markers in tumors. Seven patients with stabilization had mutations that were related to their response to therapy and were relevant to the tumor phenotype. Two patients had two mutations. The number of patients with TP53 mutations increased in HER2-positive tumor status. PD-L1-positive cancers had mutations in KRAS, TP53, PIK3CA, PTEN, and ERBB, which resulted in an increase in PD-1 expression. TP53 mutation and PTEN mutation are associated with changes in factors associated with neoangiogenesis. In concusion, patients who did not have aggressive growth markers that were verified by molecular features had the best response to treatment, including complete morphologic regression.

15 January 2024 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
VBV. A. Bogdanova
V. A. Bogdanova
LSLuidmila Spirina
Luidmila Spirina
SCSvetlana Y. Chizhevskaya
Svetlana Y. Chizhevskaya
IKIrina Kovaleva
Irina Kovaleva
КНК. В. Никульников
К. В. Никульников
СЧС. Ю. Чижевская
С. Ю. Чижевская
Melanoma of the skin and mucous membranes remains a global medical problem, which is associated with the increasing prevalence of this disease and the lack of adequate molecular genetic markers for its diagnosis and prognosis. The development of molecular approaches in the treatment of this type of tumor is associated with the identification of mutations, and with the development of immunotherapeutic and targeted drugs that can improve the effectiveness of treatment of patients with this pathology. However, the heterogeneity of the mechanisms of tumor development and the formation of resistance are a problem. It is worth noting the presence of many epigenetic mechanisms that are promising markers of the development, diagnosis and prognosis of the effectiveness of treatment of melanoma of the skin and mucous membranes. This review contains up-to-date information on the molecular mechanisms of the disease associated with the genetic characteristics of the tumor and biological factors of resistance to therapy. Of particular interest is the intersection of signaling pathways associated with melanocyte-inducing transcription factor (MITF), which is associated with transcription and growth factors, and is a target of epigenetic regulation using microRNAs and long non-coding RNAs.

9 September 2025 in South Russian Journal of Cancer
Verified
Journal Article
Open access
PDF file
VBV. A. Bogdanova
V. A. Bogdanova
LSLuidmila Spirina
Luidmila Spirina
SCSvetlana Y. Chizhevskaya
Svetlana Y. Chizhevskaya
IKIrina Kovaleva
Irina Kovaleva
КНК. В. Никульников
К. В. Никульников
СЧС. Ю. Чижевская
С. Ю. Чижевская
Purpose of the study. Was to investigate the prognostic significance of the AKT/mTOR signaling pathway components, transcription, and growth factors in the development of skin melanoma recurrence.Patients and methods. The study included 48 patients with a verified diagnosis of skin melanoma. All patients had a negative status for the BRAFV600E mutation. The study material consisted of samples of tumor and unchanged skin located at a distance of at least 1 cm from the tumor border, obtained during surgical treatment, which were frozen and stored at a temperature of –80 °C after sampling. Gene expression was assessed by real-time PCR. The status of the BRAF gene was assessed using allele-specific PCR. Statistical processing was carried out using the Statistica 12.0 software package.Results. Predicting the course of cancer is an important task in practical oncology. The unfavorable outcome of melanomas is largely due to the tendency to relapses and metastasis in both the short and long-term follow-up period. While analyzing the study results, we noted the association of AKT/mTOR signaling pathway components with the development of skin melanoma recurrence and disease progression. It was revealed that the expression level of AKT, c-RAF, GSK‑3β and VEGFR2 is associated with an unfavorable outcome of the disease. A logistic regression model is presented that can accurately predict the risk of recurrence, taking into account the expression of protein kinase mTOR and the size of the tumor (T). The lack of significant indicators related to the biological features of the skin tumor does not allow to increase the effectiveness of treatment of such patients. Therefore, the attention of researchers is focused on finding optimal models for predicting the risk of an unfavorable outcome of the disease.Conclusion. Molecular markers were identified that make it possible to predict an unfavorable outcome of the disease during the study. A logistic model based on the expression of the key mTOR kinase and the size of the T has been developed, which makes it possible to assess the risk of disease recurrence and change treatment tactics in a timely manner.

15 December 2022 in Advances in molecular oncology
Verified
Journal Article
Open access
PDF file
LSLuidmila Spirina
Luidmila Spirina
IKIrina Kovaleva
Irina Kovaleva
SCSvetlana Y. Chizhevskaya
Svetlana Y. Chizhevskaya
IKI. V. Kondakova
I. V. Kondakova
ECEvgeny L. Choynzonov
Evgeny L. Choynzonov
СЧС. Ю. Чижевская
С. Ю. Чижевская
Introduction. Biological characteristics of the tumor play a major role in it’s development and progression. Currently, using the molecular markers aimed at resolving the problems in clinical oncology is becoming more important, including thyroid carcinomas. Heterogeneous contradictory data had been accumulated to date showing the ability of tumors genetic and biological parameters to predict the diseases outcome.Aim. To investigate prognostic value of transcription, growth factors, components of AKT / mTOR signaling pathway and autophagy protein LC3B in patients with papillary thyroid cancer in relation to recurrences and overall survival.Materials and methods. The study included 65 patients with T1–4N0–1M0 papillary thyroid cancer. According to the criteria of the American Thyroid Association (ATA) (2015), patients were divided into groups of patients with high, low and intermediate risk. 30 patients were classified as low risk, 23 as intermediate risk, and 12 as high risk. The BRAFV600 mutation was identified in 18 samples. The expression of transcription factors (p65 and p50 subunits of nuclear factor kappa B (NF-κB p65, NF-κB p50), hypoxia-inducible factor 1 (HIF-1), hypoxia-inducible factor 2 (HIF-2), growth factors (vascular endothelial growth factor (VEGF), receptor VEGF (VEGF-2), carbonic anhydrases of type 9 (CAIX)), AKT, c-RAF, GSK- 3β, p70S6, mammalian target of rapamycin (m-TOR), PDK, PTEN, 4E-BP1 in the tumor was assessed by real-time polymerase chain reaction (PCR). The BRAFV600 mutation was investigated using real-time allele-specific PCR. The content of the LC3B protein was examined using the Western Blot method.Results. As a result of the study, there is an increase in c-RAF expression with an increase in risk from low to high, which was accompanied by a decrease in 4E-BP1 expression. c-RAF mRNA levels were increased 3.0- and 2.8‑fold in the intermediate and high-risk groups, respectively, compared to low risk patients. There is a change in the expression of Brn-3α depending on the relapse risk. The maximum mRNA levels were found in patients with intermediate risk, where the figure was 4.3 and 6.2 times higher than in patients with low and high risk, respectively. An increase in LC3B expression by 56.0 and 28.0 times was shown in the tumor tissue of patients with intermediate risk compared with patients with low and high risk. This fact corresponds with an increasing content of the protein itself, which was higher in patients with intermediate risk. Patients with a negative BRAF gene status had an intermediate and high risk of tumor recurrence. The prognostic significance of the estrogen receptor β (ER-β) and NF-κB p50 expression level had been revealed in relation with relapse-free and overall survival of patients with papillary thyroid cancer.Conclusion. As a result of the study, additional molecular markers were found in order to for predict the tumors recurrence risk. The study showed the significance of ERβ and NF-κB p50 expression levels for predicting disease outcomes.

2 September 2023 in Voprosy onkologii
Verified
Journal Article
Open access
LSLuidmila Spirina
Luidmila Spirina
IKIrina Kovaleva
Irina Kovaleva
SCSvetlana Y. Chizhevskaya
Svetlana Y. Chizhevskaya
ИКИрина Кондакова
Ирина Кондакова
ЕЧЕвгений Чойнзонов
Евгений Чойнзонов